Iron-chelating effect of silymarin in patients with β-thalassemia major: A crossover randomised control trial.

@article{DarvishiKhezri2018IronchelatingEO,
  title={Iron-chelating effect of silymarin in patients with β-thalassemia major: A crossover randomised control trial.},
  author={Hadi Darvishi-Khezri and Ebrahim Salehifar and Mehrnoush Kosaryan and Hossein Karami and Mohammadreza Mahdavi and Abbas Alipour and Aily Aliasgharian},
  journal={Phytotherapy research : PTR},
  year={2018},
  volume={32 3},
  pages={496-503}
}
This study aimed to determine the potential iron-chelating effects of silymarin in patients with β-thalassemia major receiving standard iron-chelation therapy. We evaluated whether addition of silymarin to standard iron-chelation therapy could improve iron burden markers and liver and cardiac function in these patients, via a placebo-controlled, crossover… CONTINUE READING